Disease | hepatitis |
Phenotype | C0022658|renal disease |
Sentences | 15 |
PubMedID- 20356392 | Clinical trials evaluating the efficacy and safety of gm-csf as an adjuvant to hepatitis b vaccine in patients with end-stage renal disease showed improved seroprotection rates with hbv vaccine after gm-csf administration [27]. |
PubMedID- 20150020 | Objective: to assess the histologic prevalence of immune-mediated thyroid, pituitary, and adrenal diseases in postmortem cases with hepatitis c. |
PubMedID- 25644891 | Detection of hepatitis c virus in patients with terminal renal disease undergoing dialysis in southern brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. |
PubMedID- 22310778 | Cryoglobulinemic membranoproliferative glomerulonephritis (mpgn) is the more characteristic renal disease associated with hepatitis c virus (hcv) infection. |
PubMedID- 21699813 | Full-dose peginterferon alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis c patients with end-stage renal disease. |
PubMedID- 22964112 | Optimization and application of subtype specific polymerase chain reaction for detection and identification of mixed subtypes of hepatitis c virus in patients with renal disease. |
PubMedID- 23716924 | renal disease associated with hepatitis c virus (hcv) infection includes membranoproliferative glomerulonephritis commonly with or without cryoglobulinemia, and membranous glomerulopathy. |
PubMedID- 22310582 | Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis b surface antigen. |
PubMedID- 24983308 | Kidney transplantation alone in end-stage renal disease patients with hepatitis b liver cirrhosis: a single-center experience. |
PubMedID- 23425817 | Eligible studies were cohort studies that analyzed adult end-stage renal disease patients with hepatitis c virus infection and compared death rates between waiting list and kidney transplantation. |
PubMedID- 21273235 | Different kinetics of hbv and hcv during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. |
PubMedID- 26095179 | Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis c in patients with end stage renal disease. |
PubMedID- 21814382 | This 38-year-old gentleman, known case of end-stage renal disease (esrd) with acute hepatitis e in resolving phase, presented to our emergency opd with complaints of multiple episodes of malena for 1 day. |
PubMedID- 25894147 | In this study, we aimed to identify the severity of liver disease in endstage renal disease patients with chronic hepatitis c virus infection, the progression of hepatic histopathology after kidney transplant, and whether immunosuppressive therapy affected posttransplant viral replication and hepatic histology. |
PubMedID- 20056985 | Objective: end-stage renal disease (esrd) patients with hepatitis c virus (hcv) infection are associated with an increasing mortality risk on hemodialysis (hd) and peritoneal dialysis (pd). |
Page: 1